Detalhe da pesquisa
1.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150388
2.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405901
3.
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.
Cancers (Basel)
; 14(7)2022 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406512
4.
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.
Clin Lymphoma Myeloma Leuk
; 21(10): e801-e809, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376375
5.
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
Cancer Med
; 9(7): 2317-2329, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32022463
6.
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.
Leuk Lymphoma
; 59(7): 1634-1643, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29165013